CSI Market
Sign In | Register

Dynavax Technologies (DVAX) Annual Balance Sheets

Annual · GAAP · USD millions
Access DVAX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Dynavax Technologies's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent95.88
Available-for-sale Securities, Debt Securities, Current MA617.95
Cash & Short-term Investments712.00
Accounts receivable45.28
Other Receivables1.63
Inventories70.05
Other Current Assets0.00
Prepaid Expense And Other Assets Current18.15
Total Current Assets848.94
Equipment/Property/Plant Net39.00
Goodwill net1.95
Long-term investments0.00
Other Assets, Noncurrent77.00
Prepaid Manufacturing0.00
Operating Lease Right Of Use Asset21.61
Total Assets986.26
Liabilities
Accounts Payable, Current AC9.06
Accrued Liabilities, Current AC61.07
Other Liabilities, Current4.20
Deferred Revenue DE0.00
Total Current Liabilities78.63
Long-term debt0.00
Convertible Notes Payable, Noncurrent LO223.85
Total Long-term Debt223.85
Other liabilities, Noncurrent86.97
Accrued Research And Development Expenses Current4.31
Coalition For Epidemic Preparedness Innovations Accruals-
Operating Lease Liability Noncurrent26.39
Total Liabilities389.46
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock1,504.67
Retained Earnings / Accumulated Deficit-903.28
Other Equity-4.72
Common Stockholder's Equity596.80
Total Stockholder's Equity596.80
Liabilities & Stockholder's Equity986.26
4 historic quarters locked

Sign in to unlock the full Dynavax Technologies balance sheet history.

Sign In Create Free Account

About Dynavax Technologies Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: February 20, 2025
  • Source: dvax-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001029142-25-000049

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License